Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: A need for screening

Clinical Infectious Diseases

Volumn 37, Issue 4, 2003, Pages 579-583

  Beltran, Sonia ^a   Lescure, François Xavier ^a   Desailloud, Rachel ^a   Douadi, Youcef ^a   Smail, Amar ^a   El Esper, Isabelle ^a   Arlot, Sylvie ^a   Schmit, Jean Luc ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LIOTHYRONINE; LOPINAVIR; RITONAVIR; STAVUDINE; THYROTROPIN; THYROXINE; VIRUS RNA;

ADULT; ARTICLE; CLINICAL TRIAL; DEMOGRAPHY; EUTHYROIDISM; FEMALE; HEPATITIS C VIRUS; HORMONE DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPOTHYROIDISM; LIPODYSTROPHY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SIDE EFFECT; SUPERINFECTION; VIRUS LOAD;

ADULT; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; HYPOTHYROIDISM; MALE; MASS SCREENING; PREVALENCE; VIRAL LOAD;

EID: 0042943232     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/376626     Document Type: Article

References (22)

1. Sellmeyer D, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev 1996; 17:518-32.
2. Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM. Metabolic complications associated with antiretroviral therapy. Antiviral Res 2001; 51:151-77.
3. Jubault V, Penfornis A, Schillo F, et al. Sequential occurrence of thyroid autoantibodies and Grave's disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. J Clin Endocrinol Metab 2000; 85:4254-7.
4. Grappin M, Piroth L, Vergès B, et al. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS 2000; 14:1070-2.
5. Cooper D. Subclinical hypothyroidism. N Engl J Med 2001; 345:260-5.
6. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41(RR-17):1-19.
7. Heufelder E, Hofbauer C. Human immunodeficiency and the thyroid gland. Eur J Endocrinol 1996; 134:669-74.
8. Grinspoon S, Bilezikian J. HIV disease and the endocrine system. N Engl J Med 1992; 327:1360-5.
9. Grunfeld C, Pang M, Doerrler W, et al. Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeflciency syndrome. Metabolism 1993; 42:1270-6.
10. Hommes MJT, Romijn JA, Endert E, et al. Hypothyroid-like regulation of the pituitary-thyroid axis in stable human immunodeficiency virus infection. Metabolism 1993; 42:556-61.
11. Tran DP, Leclerc A, Chastang JF, Goldberg M. Prévalence des problèmes de santé dans la cohorte GAZEL (EDF-GDF): répartition et disparités régionales. Rev Epidemiol Sante Publique 1994; 42:285-300.
12. Bindels A, Westendorp R, Frölich M, Seidell J, Blokstra A, Smelt A. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case finding? Clin Endocrinol (Oxf) 1999; 50:217-20.
13. Merenich J, McDermott T, Asp A, Harrison M, Kidd G. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab 1990; 70:566-71.
14. Calza L, Manfredi R, Chiodo F. Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31:361-3.
15. Brockmeyer N, Kreuter A, Bader A, Seemann U, Reimann G. Prevalence of endocrine dysfunction in HIV-infected men. Horm Res 2000; 54:294-5.
16. Collazos J, Ibarra S, Mayo J. Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era: evidence of an interrelation between the thyroid axis and the immune system. AIDS 2003; 17:763-5.
17. Raffi F, Brisseau JM, Planchon B, Rémi JP, Barrier JH, Grolleau JY. Endocrine function in 98 HIV-infected patients: a prospective study. AIDS 1991; 5:729-33.
18. Olivieri A, Sorcini M, Battisti P, et al. Thyroid hypofunction related with the progression of human immunodeficiency virus infection. J Endocrinol Invest 1993; 16:407-13.
19. O'Connor C, Sanvito M, DeCherney S. Falling CD4 counts in HIV infection: relationship to thyroid hormone and thyroid hormone binding globulin. A review and new findings. Endocrinologist 1995; 5:371-6.
20. Massabki P, Acceturi C, Nishie A, Da Silva N, Sato E, Andrade L. Clinical implications of autoantibodies in HIV infection. AIDS 1997; 11:1845-50.
21. Carella C, Mazziotti G, Morisco F, et al. Long-term outcome of interferon-α-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab 2001; 86:1925-9.
22. Poec'h K, Dubel L, Chazouilleres O, et al. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection. Am J Gastroenterol 2001; 96:2978-83.